Per I Arvidsson is Director of the national Swedish Drug Discovery & Development Platform at Science for Life Laboratory (SciLifeLab). Before being recruited by SciLifeLab & Karolinska Institutet in 2013 to build up this academic drug discovery center, Prof. Arvidsson held various roles at the CNS & Pain iMED at AstraZeneca, Södertälje – the last one as Project Director within the neurodegeneration research area. In parallel to his work at AstraZeneca, Prof. Arvidsson continued to pursue academic research as Adjunct professor in bioorganic chemistry at Uppsala University (2007-2013). Since 2013, he is also affiliated to the College of Health Science, University of KwaZulu Natal, Durban as part-time research professor. Prof. Arvidsson is named inventor on some 15+ patent applications, and co-author of more than 100 publications, two of which have won “most cited papers” awards.